Category | Source of variation | df | CCI | SNS |
---|---|---|---|---|
Control | Line | 110 | 45.43** | – |
Year | 1 | 13,217** | – | |
Rep | 2 | 3.43 | – | |
Year × Line | 103 | 16.11 | – | |
Residual | 332 | 11.77 | – | |
h 2 |  | 64.55 | – | |
SE |  | 0.29 | – | |
Metribuzin treatment | Line | 110 | 173.94** | 15.02** |
Year | 1 | 232.23 | 66.58** | |
Rep | 2 | 706.55** | 77.61** | |
Year Ă— Line | 95 | 70.89 | 3.54 | |
Residual | 214 | 90.20 | 5.63 | |
h 2 | Â | 59.22 | 76.4 | |
SE | Â | 0.95 | 0.23 |